skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello again - after reading an earlier question asked by someone spooked by the market in it current catatonic state, I recalled graphs I reviewed this morning showing institutional buying cross referenced with share prices. For many of my tech holdings ( eg. DOCN, GLBE, ESTC, PD, etc ) the graphs show steady purchasing levels by institutions even as share prices are plunging. My take on institutional investors is they are manage other people's money by and large. They are not prone to the panic, or emotional reaction, that retail investors like myself experience when we hit these air pockets. Helpful charts, at least for me and while I'm burning up one of my question credits I'd like to add how I have greatly benefited by the Portfolio Analysis tool since its inception. Using several of your suggestions, I have built a diversified portfolio that is providing a lot of insulation from the current market gale. Thanks AL
Read Answer Asked by alex on March 11, 2022
Q: What did you think of At’s conference call? Should we hold or move on?
Read Answer Asked by Mike on March 11, 2022
Q: On March 9, 2022 Kim Bolton was on BNN Market Call discussing a past pick, Sony, bought on the ADR. He recommended Sony on March 31, 2021. The pick was down 8%. A one year chart shows Sony up 76%. Is the majority of the difference due to the exchange rate? If so, is the exchange rate likely to continue in this direction? If so, it might not be advisable to buy on the ADR at this time? Your opinion please.
Thank you for the great service!
Read Answer Asked by Steven on March 11, 2022
Q: Good Morning Peter & Team

Have held ABBV for over a year now and like everyone else have done very well while enjoying a good dividend along the way.

Listened to Gordon Read this morning on Market call. He mentioned one drug which they have done very well with Humira, will be coming off patent within a year opening the door to generics. Would you agree this is going to hit their cash flow which could result in some disappointing results?

Would you consider ABBV a sell/hold/buy right now? If its a hold, when would you consider moving on? And lastly, Are there any alternative options you would recommend in place of ABBV if in fact moving on might be the recommendation?

Thanks for all you do.

gm
Read Answer Asked by Gord on March 11, 2022
Q: Can you help me understand how the volatility index works (VIX) and how an investor can use it to help determine when to start or trim a position.

Read Answer Asked by Michael on March 10, 2022
Q: Do you think if the results came out yesterday it would have gone up as much as it has come down today.
Read Answer Asked by Steve on March 10, 2022
Q: Could you comment on TA's fourth-quarter and year end results. It seems to trade at approximately 6.5 times free cash flow. How does this compare to other companies in its sector. Does it own 60% of RNW through its ownership of of TransAlta Generation Partnership which owns which owns 23% of RNW(see TransAlta Corporation | 2021 Annual Information Form)and its 37% direct ownership?
Read Answer Asked by Irwin on March 10, 2022
Q: Good morning! CVO is a listing I am following since it manifested it's interest in an IPO. Since the IPO the stock price has not performed well but is stabilizing. It is a fairly solid operation with what seems to be good management and fundamentals. I may wish to invest at some point. And I take it from your answers to recent questions that you do not have a vested interest in this listing yet.

My question is for this listing but also for any IPO out there. What are your trigger points that will initially get you interested in a listing and then that will get you invested in that listing ? Thank you.
Read Answer Asked by Roger on March 10, 2022
Q: any chance 5i listened to conference call on AcuityAds at/t....Q results didn't seem bad, & stock opened decent, at $3.50sh....but tanked after conference call..thoughts?? Couple people I know were not impressed by magt on the call.....thanks
Read Answer Asked by John on March 10, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!